SAFETY AND EFFICACY OF RUXOLITINIB (RUX) IN ELDERLY PATIENTS (>= 75 YEARS) WITH MYELOFIBROSIS (MF): AN ANALYSIS FROM THE PHASE 3B, EXPANDED-ACCESS JUMP STUDYP. Raanani,V. Gupta, P. Sadjadian,H. K. Al-Ali,P. Giraldo,P. Guglielmelli, L. Foltz,R. Tavares, A. Zaritksey, C. Bouard, J. Perez Ronco,R. Tiwari,B. MartinoHAEMATOLOGICA（2017）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
